Your browser doesn't support javascript.
loading
Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma.
Yuan, Yulin; Liu, Zimeng; Li, Bohan; Gong, Zheng; Piao, Chiyuan; Du, Yang; Zhan, Bo; Zhang, Zhe; Dong, Xiao.
Afiliação
  • Yuan Y; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Liu Z; Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Li B; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Gong Z; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Piao C; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Du Y; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Zhan B; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Zhang Z; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Dong X; Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Front Cell Dev Biol ; 10: 977960, 2022.
Article em En | MEDLINE | ID: mdl-36407113

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article